+44 (0) 1223 755950
+1 832 327 7413
orders@abbexa.com
Click on the image to see the image legend
Target | Cyclin Dependent Kinase Inhibitor 1A Phospho-Thr145 (CDKN1A pT145) |
Clonality | Polyclonal |
Target Modification | Thr145 |
Modification | Phosphorylation |
Reactivity | Human, Mouse, Rat |
Tested Applications | ELISA, WB, IHC |
Host | Rabbit |
Recommended dilutions | ELISA: 1/10000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/300. Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Immunogen | Synthesized peptide derived from human CDKN1A/p21 around the phosphorylation site of T145. |
Isotype | IgG |
Form | Liquid |
Purification | Purified by affinity chromatography. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | P38936 (UniProt, ExPASy) |
UniProt Secondary AC | Q14010, Q6FI05, Q9BUT4 |
UniProt Entry Name | CDN1A_HUMAN |
Gene Symbol | CDKN1A |
GeneID | 1026 |
KEGG | hsa:1026 |
String | 9606.ENSP00000384849 |
Buffer | PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
Concentration | 1 mg/ml |
Availability | Shipped within 5-10 working days. |
Note | This product is for research use only. |